Left ventricular outflow tract obstruction

WikiDoc Resources for Left ventricular outflow tract obstruction
Articles
Most recent articles on Left ventricular outflow tract obstruction Most cited articles on Left ventricular outflow tract obstruction Review articles on Left ventricular outflow tract obstruction Articles on Left ventricular outflow tract obstruction in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Left ventricular outflow tract obstruction Images of Left ventricular outflow tract obstruction Photos of Left ventricular outflow tract obstruction Podcasts & MP3s on Left ventricular outflow tract obstruction Videos on Left ventricular outflow tract obstruction
Evidence Based Medicine
Cochrane Collaboration on Left ventricular outflow tract obstruction Bandolier on Left ventricular outflow tract obstruction TRIP on Left ventricular outflow tract obstruction
Clinical Trials
Ongoing Trials on Left ventricular outflow tract obstruction at Clinical Trials.gov Trial results on Left ventricular outflow tract obstruction Clinical Trials on Left ventricular outflow tract obstruction at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Left ventricular outflow tract obstruction NICE Guidance on Left ventricular outflow tract obstruction NHS PRODIGY Guidance FDA on Left ventricular outflow tract obstruction CDC on Left ventricular outflow tract obstruction
Books
Books on Left ventricular outflow tract obstruction
News
Left ventricular outflow tract obstruction in the news Be alerted to news on Left ventricular outflow tract obstruction News trends on Left ventricular outflow tract obstruction
Commentary
Blogs on Left ventricular outflow tract obstruction
Definitions
Definitions of Left ventricular outflow tract obstruction
Patient Resources / Community
Patient resources on Left ventricular outflow tract obstruction Discussion groups on Left ventricular outflow tract obstruction Patient Handouts on Left ventricular outflow tract obstruction Directions to Hospitals Treating Left ventricular outflow tract obstruction Risk calculators and risk factors for Left ventricular outflow tract obstruction
Healthcare Provider Resources
Symptoms of Left ventricular outflow tract obstruction Causes & Risk Factors for Left ventricular outflow tract obstruction Diagnostic studies for Left ventricular outflow tract obstruction Treatment of Left ventricular outflow tract obstruction
Continuing Medical Education (CME)
CME Programs on Left ventricular outflow tract obstruction
International
Left ventricular outflow tract obstruction en Espanol Left ventricular outflow tract obstruction en Francais
Business
Left ventricular outflow tract obstruction in the Marketplace Patents on Left ventricular outflow tract obstruction
Experimental / Informatics
List of terms related to Left ventricular outflow tract obstruction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Left ventricular outflow tract obstruction refers to any functional or anatomic obstruction of flow out of the left ventricle.

Causes

• Aortic stenosis
• Hypertrophic obstructive cardiomyopathy
• Stress cardiomyopathy
• Subvalvular aortic stenosis
• Supravalvular aortic stenosis

ACC / AHA 2008 Guidelines- Recommendations for Evaluation of the Unoperated Patient (DO NOT EDIT)

Class I

1. Primary imaging and hemodynamic assessment of AS and aortic valve disease are recommended by echocardiography- Doppler to evaluate the presence and severity of AS or AR; LV size, function, and mass; and dimensions and anatomy of the ascending aorta and associated lesions. (Level of Evidence: B)

2. Echocardiography is recommended for reevaluation of patients with AS who experience a change in signs or symptoms and for assessment of changes in AS hemodynamics during pregnancy. (Level of Evidence: B)

3. In asymptomatic adolescents and young adults, echocardiography- Doppler is recommended yearly for AS with a mean Doppler gradient greater than 30 mm Hg or peak instantaneous gradient greater than 50 mm Hg and every 2 years for patients with lesser gradients.(Level of Evidence: C)

4. Cardiac catheterization is recommended when noninvasive measurements are inconclusive or discordant with clinical signs. (Level of Evidence:C)

5. Coronary angiography is recommended before aortic valve surgery for coronary angiography in adults at risk for coronary artery disease. (Level of Evidence:B)

6. Coronary angiography is recommended before a Ross procedure if noninvasive imaging of the coronary arteries is inadequate. (Level of Evidence:C)

7. A yearly ECG is recommended in young adults less than 30 years of age with mean Doppler gradients greater than 30 mm Hg or peak Doppler gradients greater than 50 mm Hg. (Level of Evidence:C)

8. An ECG is recommended every other year in young adults less than 30 years of age with mean Doppler gradients less than 30 mm Hg or peak Doppler gradients less than 50 mm Hg. (Level of Evidence:C)

Class III

1. Exercise stress testing should not be performed in symptomatic patients with AS or those with repolarization abnormality on ECG or systolic dysfunction on echocardiography.(Level of Evidence: B)

Class IIb

1. In asymptomatic young adults less than 30 years of age, exercise stress testing is reasonable to determine exercise capability, symptoms, and blood pressure response. (Level of Evidence:C)

2. Exercise stress testing is reasonable for patients with a mean Doppler gradient greater than 30 mm Hg or peak Doppler gradient greater than 50 mm Hg if the patient is interested in athletic participation or if clinical findings differ from noninvasive measurements. (Level of Evidence:C)

3. Exercise stress testing is reasonable for the evaluation of an asymptomatic young adult with a mean Doppler gradient greater than 40 mm Hg or a peak Doppler gradient greater than 64 mm Hg or when the patient anticipates athletic participation or pregnancy. (Level of Evidence:C)

4. Dobutamine stress testing can be beneficial in the evaluation of a mild aortic valve gradient in the face of low LV ejection fraction and reduced cardiac output. (Level of Evidence:B)

5. MRI/CT can be beneficial to add important information about the anatomy of the thoracic aorta. (Level of Evidence:C)

6. Exercise stress testing can be useful to evaluate blood pressure response or elicit exercise-induced symptoms in asymptomatic older adults with AS. (Level of Evidence:B)

Class IIb

1. Magnetic resonance angiography may be beneficial in quantifying AR when other data are ambiguous or borderline. (Level of Evidence:C)

---

ACC/ AHA Guidelines - Recommendation for Medical Therapy for Left Ventricular Outflow Tract Obstruction and Associated Lesions (DO NOT EDIT)

Class III

1. Vasodilator therapy is not indicated for long-term therapy in AR for the following:

a. The asymptomatic patient with only mild to moderate AR and normal LV function. (Level of Evidence: B)

b. The asymptomatic patient with LV systolic dysfunction who is otherwise a candidate for aortic valve replacement (AVR). (Level of Evidence: B)

c. The asymptomatic patient with either LV systolic function or mild to moderate LV diastolic dysfunction who is otherwise a candidate for AVR. (Level of Evidence: C)